What is the clinical significance of a ferritin level of 559 µg/L and what further evaluation is recommended?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ferritin of 559 µg/L: Clinical Significance and Evaluation

A ferritin of 559 µg/L is moderately elevated and requires evaluation with transferrin saturation (TSAT) as the critical next step to distinguish iron overload from inflammatory/metabolic causes—most patients with this level do NOT have true iron overload.

Initial Assessment Priority

The key discriminating test is transferrin saturation (TSAT) 1, 2, 3, 4:

  • TSAT >40-45%: Suggests true iron overload → proceed to HFE genotyping (C282Y/H63D) in Caucasian patients 3
  • TSAT <40-45%: Indicates inflammatory, metabolic, or reactive hyperferritinemia → evaluate alternative causes 2

Most Likely Etiologies at This Level

At 559 µg/L, you are dealing with moderate hyperferritinemia. The vast majority of cases do NOT represent iron overload 1. The most common causes are:

  • Metabolic syndrome (insulin resistance, obesity, fatty liver) 3, 4
  • Alcohol consumption 5, 3
  • Inflammatory conditions (ferritin is an acute phase reactant) 1, 4
  • Liver disease 4
  • Medications: SGLT2 inhibitors alter ferritin interpretation 1

Algorithmic Workup

Step 1: Check TSAT

  • If TSAT >45% → HFE genetic testing for hereditary hemochromatosis
  • If TSAT normal → proceed to Step 2

Step 2: Evaluate for Secondary Causes

Look specifically for:

  • Metabolic factors: BMI, waist circumference, glucose/HbA1c, lipid panel
  • Alcohol intake: Quantify weekly consumption
  • Inflammatory markers: CRP, ESR if clinically indicated
  • Liver function: AST, ALT, GGT
  • Medications: Document SGLT2 inhibitors, GLP-1 agonists 1

Step 3: Consider Iron Overload Assessment if Unclear

If TSAT is borderline (40-45%) or diagnosis remains uncertain:

  • Hepatic MRI (T2* or R2*) is the reference standard for quantifying liver iron content 3
  • Soluble transferrin receptor (sTfR) can help distinguish iron deficiency from inflammation 1

Critical Thresholds to Remember

  • Ferritin >1000 µg/L: Warrants liver fibrosis evaluation (elastography, imaging, or biopsy) 2
  • Ferritin >10,000 µg/L: Consider hemophagocytic lymphohistiocytosis (HLH), though adult sensitivity is lower (82-95%) than pediatric 1
  • For hemochromatosis monitoring: Target ferritin 50-100 µg/L during maintenance 5

Common Pitfalls

  1. Over-diagnosing iron overload: 40-70% of hyperferritinemia cases are multifactorial 2. Don't assume iron overload without elevated TSAT.

  2. Missing metabolic hyperferritinemia: This is increasingly common and associated with insulin resistance, not true iron excess 1, 3.

  3. Ignoring medication effects: SGLT2 inhibitors definitively alter ferritin; GLP-1 agonists may as well 1.

  4. Unnecessary phlebotomy: Without confirmed iron overload (elevated TSAT + genetic confirmation or MRI evidence), phlebotomy is inappropriate and potentially harmful.

Monitoring Strategy

If no clear cause is identified initially:

  • Recheck ferritin and TSAT in 3-6 months 2
  • Stability or decrease in levels makes iron overload disease unlikely 2
  • Persistent elevation with normal TSAT suggests inflammatory/metabolic etiology

When to Refer

Consider hematology or hepatology referral if:

  • TSAT >45% with elevated ferritin
  • Ferritin >1000 µg/L
  • Evidence of liver disease or fibrosis
  • Diagnostic uncertainty after initial workup 3

References

Research

Non-invasive diagnosis and follow-up of hyperferritinaemia.

Clinics and research in hepatology and gastroenterology, 2022

Research

Investigation and management of a raised serum ferritin.

British journal of haematology, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.